Average Co-Inventor Count = 9.07
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Biotech, Inc. (17 from 410 patents)
2. Janssen Pharmaceutica Nv (3 from 2,078 patents)
3. Jansson Biotech, Inc. (1 from 1 patent)
21 patents:
1. 12234280 - Anti-PHF-tau antibodies and uses thereof
2. 11732050 - Neutralizing human anti-CD27 antibodies
3. 11414484 - Anti-CCL17 antibodies
4. 10829549 - Anti-CCL17 antibodies
5. 10689453 - Methods of inhibiting naive T-cell proliferation using anti-CD27 antibodies
6. 10633435 - Anti-PHF-tau antibodies and uses thereof
7. 10450377 - ST2L antagonists and methods of use
8. 10301392 - Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodies
9. 9951137 - ST2L antagonists and methods of use
10. 9944697 - Anti-CCL17 antibodies
11. 9850310 - CD123 binding agents and uses thereof
12. 9683046 - Nucleic acid molecules encoding anti-CD27 antibodies
13. 9248194 - Affinity peptides toward infliximab
14. 9212227 - ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions
15. 9102737 - Human anti-CD27 antibodies, methods and uses